Fig. 14From: Sample size determination for point-of-care COVID-19 diagnostic tests: a Bayesian approachSample sizes obtained via BAM (with pessimistic lab data included) vs. alternative methods for both sensitivity and specificity when assurance/power is 0.8Back to article page